- Lobbying
- Lobbying by Pyng Medical USA
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Jeff Markey | L.D./Deputy COS, Representative Doc Hastings Legislative Director, Representative Jack Metcalf Graduate Fellow, US Department of State Intern, Senator John Seymour |
Rick Desimone | Chief of Staff, Senator Patty Murray GSA, Special Asst to Regional Admin., Reg. 10 |
Holland Patterson | Deputy White House Liaison for DOD |
Shannon O'Keefe | Deputy Associate Director, Leg. Affairs, OMB Prof. Staff Homeland Security Approps Subcommittee Prof. Staff Commerce, Justice, Science Subcommittee Research Analyst, Asst Sec. for Plan. and Eval., HHS |
Elizabeth Phillips | Professional Staff - Surveys/Investigation, Appropriations Committee; Director of Joint Strategy Planning & Assessment Office, Dept. of State; Professional Staff, Appropriations Committee Prof Staff - Surveys/Investigation, Approps Comm. Dir of Joint Str. Planning & Assessment Off., DOS Prof Staff, Appropriations Committee |
Holland Patterson Burton | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Termination
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Amendment
Lobbying Issues
Agencies Lobbied
Type of Issue
Lobbying Issues
Agencies Lobbied
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Lobbying Issues
Agencies Lobbied
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Lobbying Issues
Agencies Lobbied
Type of Issue
Lobbying Issues
Agencies Lobbied
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Lobbying Issues
Agencies Lobbied
Type of Issue
Lobbying Issues
Agencies Lobbied
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Lobbying Issues
Agencies Lobbied
Type of Issue
Lobbying Issues
Agencies Lobbied
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Registration
Issue(s) they said they’d lobby about: Development of advanced medical technologies..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate